mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.3 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.33 |
0.3 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
-0.2 |
0.3 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
-0.052 |
0.3 |